PANDEL (PharmaDerm a division of Fougera Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the PANDEL drug offered from PharmaDerm a division of Fougera Pharmaceuticals Inc.. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | PharmaDerm a division of Fougera Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | HYDROCORTISONE PROBUTATE |
SUBSTANCE NAME: | HYDROCORTISONE PROBUTATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
ROUTE: | TOPICAL |
DOSAGE FORM: | CREAM |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1997-02-28 |
END MARKETING DATE: | 0000-00-00 |
PANDEL HUMAN PRESCRIPTION DRUG Details:
Item Description | PANDEL from PharmaDerm a division of Fougera Pharmaceuticals Inc. |
LABELER NAME: | PharmaDerm a division of Fougera Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/g) |
START MARKETING DATE: | 1997-02-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 10337-153_05460f8a-bc79-428d-a26a-7470df536d3e |
PRODUCT NDC: | 10337-153 |
APPLICATION NUMBER: | NDA020453 |
Other HYDROCORTISONE PROBUTATE Pharmaceutical Manufacturers / Labelers: